Skip to main content

Full Schedule

Full Schedule

  • Wednesday, June 29, 2022
  • 10:30 – 12:30
    Expert Consensus Discussion on HCC (by invitation only)
  • 11:15 – 12:45
    The BTC Patient Journey: Best Practices and Current Challenges 

    Session Chair: Teresa Macarulla, MD, PhD – Vall d’Hebrón University Hospital

    Supported by AstraZeneca
  • 13:00 – 13:30
    Session I: Opening Session

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

  • 13:30 – 16:15
    Session II: Cancer of the Pancreas

    Chair: Margaret A. Tempero, MD – UCSF

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

  • 16:15 – 16:40
    Break
  • 16:15 – 17:00
    ESMO Vesalius Talk: How to find Local and International Mentors to Build Your Career in GI Oncology
  • 16:40 – 18:45
    Session III: Cancer of the Biliary Tract

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

    Chair: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital

  • 19:00 – 20:30
    Current Highlights and Future Strategies for GI

    Session Chair: Markus Moehler, MD – Universitätsmedizin Mainz

    Supported by EORTC
  • 19:00 – 21:00
    18th ESO Colorectal Cancer Observatory: Innovation and Care in the Next 12 Months

    Session Chair: Mario A. Dicato, MD – Luxembourg Medical Center

    Supported by European School of Oncology (ESO)
  • 19:00 – 21:00
    Personalized GI Oncology in Europe - State of the Art and Future Perspectives

    Session Chair: Thomas T. Seufferlein, MD, PhD – Ulm University

    Session Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Supported by European Society of Digestive Oncology
  • Thursday, June 30, 2022
  • 08:00 – 09:25
    Session IV: ESMO Session: Focus on Young Oncologists (YO) in Collaboration With ESMO Young Oncologist Committee (YOC)
  • 08:00 – 09:25
    Session V: Presentation of Selected Non-Colorectal Cancer Abstracts

    Chair: Florian Lordick, MD, PhD – Leipzig University Medical Center

    Chair: Juan Manuel O'Connor, MD, MSc – Instituto Alexander Fleming

  • 08:00 – 09:25
    Session VIA: GI Cancer in Elderly: Challenges and Prospects

    Panelist: Demetris Papamichael, MB BS FRCP – Bank of Cyprus Oncology Centre

    Panelist: Radka Obermannova, MD, PhD – Masaryk Memorial Cancer Institute and Masaryk University

    Speaker: Harriet Baker, MD – Cambridge University Hospitals, NHS Foundation Trust

    Speaker: Simona Borilova, MD – Masaryk Memorial Cancer Institute

    Speaker: Maike Collienne, MD – Asklepios Tumorzentrum Hamburg, AK Altona; European Organization for Research and Treatment of Cancer (EORTC)

    Speaker: Benjamin Kobitzsch, MD – University Cancer Center Leipzig

    Speaker: Ching Leung, MD – Cambridge University Hospitals, NHS Foundation Trust

    Speaker: Christiana Matthaiou – Cyprus Oncology Center

    Speaker: Rita Saude-Conde – Institut Jules Bordet

    Speaker: Gertraud Stocker, MD – University Cancer Center Leipzig

  • 08:00 – 09:25
    Session VIB: Multidisciplinary Case Discussion on Oligometastatic GI Cancer

    Moderator: Josep Tabernero, MD – Vall d’Hebron University Hospital

    Moderator: Harpreet S. Wasan, MD FRCP – Hammersmith Hospital, Imperial College London

    Panelist: Thomas Gruenberger, MD – Clinic Favoriten, Dept Surgery, HPB Center, health network Vienna

    Panelist: Vincent Vandecaveye, MD, PhD – University Hospitals Leuven - KU Leuven

    Panelist: Pia Osterlund, MD PhD Prof – Tampere university hospital and Karolinska Hospital/Institutet

    Panelist: Gerald Prager, MD – Medizinische Universität Wien

    Panelist: Jerôme Durand-Labrunie, MD, MSc – Gustave Roussy

  • 08:00 – 08:45
    Session VII: Meet the Experts: Challenging Cases in Advanced HCC

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

    Chair: Ghassan K. Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center

    Panelist: Bruno Sangro, MD, PhD – Clinica Universidad de Navarra

    Panelist: Arndt Vogel, MD – Medizinische Hochschule Hannover

    Panelist: René André Adam, MD, PhD – Paul Brousse Hospital

    Panelist: Thierry de Baere, MD – Institut Gustave Roussy

    Educational activity provided by ESMO WCGIC and supported by Bayer
  • 09:30 – 10:00
    Break and Poster Viewing
  • 10:00 – 12:50
    Session VIII: Esophageal and Gastric Cancers

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Andrés Cervantes, MD, PhD – Biomedical Research institute INCLIVA, University of Valencia, Hospital Clínico de Valencia

  • 12:50 – 13:05
    Break
  • 13:05 – 14:35
     A Continuum of Care: The Multidisciplinary Management of HCC 

    Session Chair: Bruno Sangro, MD, PhD – Clinica Universidad de Navarra

    Supported by AstraZeneca
  • 13:05 – 14:35
    Cholangiocarcinoma: It's Time for Personalised Medicine

    Session Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Session Chair: Lorenza Rimassa

    Supported by Incyte
  • 13:05 – 14:35
    Navigating the Patient Journey in mCRC and mGC

    Session Chair: Julien Taieb – Hôpital Euopéen Georges-Pompidou

    Supported by Servier
  • 14:50 – 18:35
    Session IX: Hepatocellular Cancer

    Chair: Thomas Gruenberger, MD – Clinic Favoriten, Dept Surgery, HPB Center, health network Vienna

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

  • 17:15 – 17:45
    Break and Poster Viewing
  • 17:15 – 17:45
    ESMO Lounge Session: Gender Medicine: Time to Address the Topic in GI Tumors
  • 18:50 – 19:50
    WCGIC Colloqium 1: Artificial Intelligence in GI Oncology
  • 18:50 – 19:50
    WCGIC Colloquium 2: Molecular Marker Platforms

    Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital

    Chair: Scott Kopetz, MD, PhD – University of Texas MD Anderson Cancer Center

    Panelist: Dirk Arnold, MD PhD – Asklepios Tumorzentrum Hamburg

    Panelist: Ryan Corcoran, MD PhD – MGH Cancer Center

    Panelist: Heinz-Josef Lenz, MD – University of Southern California

    Panelist: Pierre Laurent-Puig, MD. PhD – Université de Paris

  • 18:50 – 19:50
    WCGIC Colloquium 3: NET Tumors

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

    Chair: Chris J. Verslype, MD PhD – University Hospital Gasthuisberg

    Panelist: Angela Lamarca, MD, PhD – Fundacion Jimenez Diaz University Hospital

    Panelist: Christophe M. Deroose, Prof. Dr. – University Hospitals Leuven / KU Leuven

    Panelist: Thomas Gruenberger, MD – Clinic Favoriten, Dept Surgery, HPB Center, health network Vienna

    Panelist: Juan Manuel O'Connor, MD, MSc – Instituto Alexander Fleming

  • 19:50 – 20:50
    Welcome Reception; Travel Grant and Young Investigator Award Ceremony
  • Friday, July 1, 2022
  • 08:00 – 09:25
    Session X: Presentation of Selected Colorectal Cancer Abstracts

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center

  • 08:00 – 09:25
    Session XI: Minisymposium: The Role of Functional Imaging in GI Cancer

    Chair: Gina Brown, MD – Imperial College

    Chair: Raquel Perez-Lopez, MD, PhD – Vall d'Hebron Institute of Oncology

  • 08:00 – 09:25
    Session XII: Minisymposium: Special Topics in Young Adults with Cancer

    Chair: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center

    Chair: Erika Ruiz-Garcia, MD, MSc – Instituto Nacional de Cancerologia

  • 08:00 – 08:45
    Session XIII: Meet the Experts: Customized Dosing for Kinase Inhibitors

    Chair: Tanios Bekaii-Saab, MD – Mayo Clinic

    Educational activity provided by ESMO WCGIC and supported by Bayer
  • 09:30 – 10:20
    Session XIV: Keynote Lectures

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

  • 10:20 – 10:50
    Break and Poster Viewing
  • 10:50 – 13:25
    Session XV: Rectal Cancer

    Chair: André JL D'Hoore, MD, PhD – University Hospital Gasthuisberg

    Chair: Deborah Mukherji, MBBS – American University of Beirut Medical Center

  • 13:40 – 15:10
    Evolving Therapeutic Strategies in Advanced GI Cancers

    Session Chair: Ruth Vera

    Supported by Amgen
  • 13:40 – 15:10
    Managing Patients with Difficult to Treat Cancers – Insights into Pancreatic Cancer and Cholangiocarcinoma

    Session Chair: Thomas T. Seufferlein, MD, PhD – Ulm University

    Supported by Servier
  • 13:40 – 15:10
    Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance with Targeted Agents

    Session Chair: Elena Elez, Sr., MD PhD – Vall Hebron University Hospital

    Session Chair: Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center

    Educational activity provided by PeerView Live and supported by Daiichi Sankyo, Inc.
  • 13:40 – 15:10
    See the Difference: Clinical Implications of BRAFV600E-mutant Metastatic CRC

    Session Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital

    Supported by Pierre Fabre
  • 15:25 – 16:25
    Session XVI: Adjuvant Colon Cancer

    Chair: Thierry André, MD – Hopital Saint Antoine

    Chair: Alberto F. Sobrero, prof – IRCCS Ospedale San Martino IST

  • 16:30 – 17:00
    Break and Poster Viewing
  • 16:30 – 17:15
    ESMO Lounge Session: Disparities in Access to New Drugs: How to Tackle the Reality?

    Chair: Claudia Cardone, MD, PhD – Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale”

    Chair: Rille Pihlak, MD, PhD – St Bart's Hospital

    Chair: Elene Mariamidze, MD – Todua Clinic

    Speaker: Rosa Giuliani, MD – The Clatterbridge Cancer Centre

  • 16:35 – 16:55
    Poster Discussion Guided Tours - Group 4: Basic Colon Cancer (PD-11, PD-13)
  • 16:35 – 16:55
    Poster Discussion Guided Tours - Group 5: Clinical Colon Cancer (PD-12, PD-14)
  • 17:00 – 18:05
    Session XVII: Immune Mechanisms and Immunotherapy

    Chair: Mario A. Dicato, MD – Luxembourg Medical Center

    Chair: Markus Moehler, MD – Universitätsmedizin Mainz

  • 18:05 – 19:00
    Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients

    Chair: Sharlene Gill, MD, MPH, MBA – BC Cancer - University of British Columbia

    Chair: Juan Manuel O'Connor, MD, MSc – Instituto Alexander Fleming

  • Saturday, July 2, 2022
  • 08:15 – 09:25
    Session XIX: Presentation of Selected Abstracts on GI Cancer

    Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital

    Chair: Pierre Laurent-Puig, MD. PhD – Université de Paris

  • 08:30 – 09:25
    Session XX: Women for Oncology: The Construction of the Majority Minority

    Chair: Erika Ruiz-Garcia, MD, MSc – Instituto Nacional de Cancerologia

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

  • 08:30 – 09:25
    Session XXI: Surgical Advances in GI Oncology: Transplantation and Robotics

    Chair: René André Adam, MD, PhD – Paul Brousse Hospital

    Chair: Thomas Gruenberger, MD – Clinic Favoriten, Dept Surgery, HPB Center, health network Vienna

  • 09:30 – 13:15
    Session XXII: Colorectal Cancer: Metastatic Disease

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Pia Osterlund, MD PhD Prof – Tampere university hospital and Karolinska Hospital/Institutet

  • 13:30 – 15:00
    A tumor informed approach in the management of GI cancers

    Session Chair: Adham Jurdi, MD

    Supported by Natera
  • 13:30 – 15:00
    An Overview of Regorafenib in Gastrointestinal Cancers: A Lunch Clinical Research Update

    Session Chair: Tanios Bekaii-Saab, MD – Mayo Clinic

    Educational activity provided by ESMO WCGIC and supported by Bayer.
  • 13:30 – 15:00
    Expert Perspectives on Checkpoint Inhibitors in Gastric Cancer 

    Session Chair: Florian Lordick, MD, PhD – Leipzig University Medical Center

    Supported by Novartis
  • 13:30 – 15:00
    Optimizing Treatment Approaches and Evolution of HER2 Targeting in mCRC

    Session Chair: Thierry André, MD – Hopital Saint Antoine

    Supported by Seagen
  • 15:15 – 16:30
    Session XXIII: Rare GI Tumors – NETs, GISTs, and Anal Cancer

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy